Silence Therapeutics plc (SLN)
NASDAQ: SLN · IEX Real-Time Price · USD
21.25
+0.59 (2.86%)
Apr 16, 2024, 4:00 PM EDT - Market closed

Silence Therapeutics Statistics

Total Valuation

SLN has a market cap or net worth of $988.17 million. The enterprise value is $921.36 million.

Market Cap 988.17M
Enterprise Value 921.36M

Important Dates

The next estimated earnings date is Tuesday, May 14, 2024, before market open.

Earnings Date May 14, 2024
Ex-Dividend Date n/a

Share Statistics

SLN has 46.50 million shares outstanding. The number of shares has increased by 7.74% in one year.

Shares Outstanding 46.50M
Shares Change (YoY) +7.74%
Shares Change (QoQ) +6.93%
Owned by Insiders (%) 16.99%
Owned by Institutions (%) 44.60%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 30.76
Forward PS n/a
PB Ratio 46.63
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 28.68
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.56, with a Debt / Equity ratio of 0.02.

Current Ratio 4.56
Quick Ratio 3.05
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -22.38

Financial Efficiency

Return on equity (ROE) is -262.60% and return on invested capital (ROIC) is -286.36%.

Return on Equity (ROE) -262.60%
Return on Assets (ROA) -47.00%
Return on Capital (ROIC) -286.36%
Revenue Per Employee $294,681
Profits Per Employee -$502,462
Employee Count 109
Asset Turnover 0.28
Inventory Turnover n/a

Taxes

Income Tax -8.75M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +260.95% in the last 52 weeks. The beta is 1.40, so SLN's price volatility has been higher than the market average.

Beta (1Y) 1.40
52-Week Price Change +260.95%
50-Day Moving Average 22.96
200-Day Moving Average 13.80
Relative Strength Index (RSI) 41.75
Average Volume (30 Days) 253,329

Short Selling Information

Short Interest 162,012
Short Previous Month 92,658
Short % of Shares Out 0.35%
Short % of Float n/a
Short Ratio (days to cover) 0.67

Income Statement

In the last 12 months, SLN had revenue of $32.12 million and -$54.77 million in losses. Loss per share was -$1.45.

Revenue 32.12M
Gross Profit 18.71M
Operating Income -61.65M
Pretax Income -62.53M
Net Income -54.77M
EBITDA -59.28M
EBIT -59.85M
Loss Per Share -$1.45
Full Income Statement

Balance Sheet

The company has $67.15 million in cash and $338,053 in debt, giving a net cash position of $66.81 million or $1.44 per share.

Cash & Cash Equivalents 67.15M
Total Debt 338,053
Net Cash 66.81M
Net Cash Per Share $1.44
Equity / Book Value 21.19M
Book Value Per Share 0.46
Working Capital 78.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$48.91 million and capital expenditures -$55,928, giving a free cash flow of -$48.96 million.

Operating Cash Flow -48.91M
Capital Expenditures -55,928
Free Cash Flow -48.96M
FCF Per Share -$1.27
Full Cash Flow Statement

Margins

Gross margin is 58.26%, with operating and profit margins of -191.93% and -170.51%.

Gross Margin 58.26%
Operating Margin -191.93%
Pretax Margin -194.67%
Profit Margin -170.51%
EBITDA Margin -184.55%
EBIT Margin -186.34%
FCF Margin -152.43%

Dividends & Yields

SLN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.74%
Shareholder Yield -7.74%
Earnings Yield -5.54%
FCF Yield -4.95%

Analyst Forecast

The average price target for SLN is $57.25, which is 169.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target $57.25
Price Target Difference 169.41%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SLN has an Altman Z-Score of 1.06 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.06
Piotroski F-Score 3